Antiviral properties of silver nanoparticles on a magnetic hybrid colloid.
Silver nanoparticles (AgNPs) are considered to be a potentially useful tool for controlling various pathogens. However, there are concerns about the release of AgNPs into environmental media, as they may generate adverse human health and ecological effects. In this study, we developed and evaluated a novel micrometer-sized magnetic hybrid colloid (MHC) decorated with variously sized AgNPs (AgNP-MHCs). After being applied for disinfection, these particles can be easily recovered from environmental media using their magnetic properties and remain effective for inactivating viral pathogens. We evaluated the efficacy of AgNP-MHCs for inactivating bacteriophage ΦX174, murine norovirus (MNV), and adenovirus serotype 2 (AdV2). These target viruses were exposed to AgNP-MHCs for 1, 3, and 6 h at 25°C and then analyzed by plaque assay and real-time TaqMan PCR. The AgNP-MHCs were exposed to a wide range of pH levels and to tap and surface water to assess their antiviral effects under different environmental conditions. Among the three types of AgNP-MHCs tested, Ag30-MHCs displayed the highest efficacy for inactivating the viruses. The ΦX174 and MNV were reduced by more than 2 log10 after exposure to 4.6 × 10(9) Ag30-MHCs/ml for 1 h. These results indicated that the AgNP-MHCs could be used to inactivate viral pathogens with minimum chance of potential release into environment.
Department of Environmental Health, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.
SungJun
S
Park
Hye Hun
HH
Park
Sung Yeon
SY
Kim
Su Jung
SJ
Kim
Kyoungja
K
Woo
GwangPyo
G
Ko
D000256:Adenoviridae / Q000187:drug effects / Q000502:physiology; D000998:Antiviral Agents / Q000494:pharmacology*; D010584:Bacteriophage phi X 174 / Q000187:drug effects / Q000502:physiology; D003102:Colloids; D004337:Drug Carriers; D008280:Magnetics; D050296:Microbial Viability; D053758:Nanoparticles; D029322:Norovirus / Q000187:drug effects / Q000502:physiology; D060888:Real-Time Polymerase Chain Reaction; D012834:Silver / Q000494:pharmacology*; D010948:Viral Plaque Assay
D000998:Antiviral Agents; D003102:Colloids; D004337:Drug Carriers; D012834:Silver